UMass Chan Affiliations
Department of Medicine, Division of RheumatologyDocument Type
Journal ArticlePublication Date
2013-06-01
Metadata
Show full item recordAbstract
Targeted biologic therapies markedly slow the progression of structural damage in rheumatoid arthritis (RA); thus, the presence of bony erosion suggests that had treatment been initiated earlier, joint damage might have been prevented. Some patients with early inflammatory arthritis, the group most likely to benefit from prompt initiation of treatment, are not classified as having RA using the 1987 American Rheumatism Association classification criteria.Source
Nat Rev Rheumatol. 2013 Jun;9(6):323-4. doi: 10.1038/nrrheum.2013.60. Link to article on publisher's siteDOI
10.1038/nrrheum.2013.60Permanent Link to this Item
http://hdl.handle.net/20.500.14038/30523PubMed ID
23609778Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1038/nrrheum.2013.60